Rekah Pharmaceutical Industry Ltd (REKA) — Long-term Investment Intensity

Latest as of December 2015: 0.2%

Rekah Pharmaceutical Industry Ltd (REKA) has a Long-term Investment Intensity of 0.2% as of December 2015. Long-term investments of ILA610.00K represent 0.2% of total assets of ILA323.82 Million. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. Check REKA capex plus investments ratio to assess the company's total reinvestment commitment from operating cash flow.

LT Investment Intensity

0.2%
LT Investments / Total Assets

Long-term Investments

ILA610.00K
ILA

Total Assets

ILA323.82 Million
ILA

Country

Israel
TA

Rekah Pharmaceutical Industry Ltd Long-term Investment Intensity (2015–2015)

This chart shows how Rekah Pharmaceutical Industry Ltd's Long-term Investment Intensity has evolved across 1 annual periods from 2015 to 2015. As of December 2015, the intensity stands at 0.2%, reflecting long-term investments of ILA610.00K against total assets of ILA323.82 Million ILA. Explore cash flow to debt ratio of Rekah Pharmaceutical Industry Ltd to assess how comfortably operating cash covers total debt obligations.

Annual Long-term Investment Intensity for Rekah Pharmaceutical Industry Ltd (2015–2015)

The table below presents the year-by-year Long-term Investment Intensity for Rekah Pharmaceutical Industry Ltd from 2015 to 2015, covering 1 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. For market capitalisation and broader financial context, see Rekah Pharmaceutical Industry Ltd market cap and net worth.

Year LT Investment Intensity LT Investments (ILA) Total Assets Change (pp)
2015 0.2% ILA610.00K ILA323.82 Million
pp = percentage points